FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3135179372> ?p ?o ?g. }

• W3135179372 endingPage "e048398" @default.
• W3135179372 startingPage "e048398" @default.
• W3135179372 abstract "Introduction Although antibiotic prophylaxis is established in reducing postoperative surgical site infections (SSIs), the optimal antibiotic for prophylaxis in pancreatoduodenectomy (PD) remains unclear. The study objective is to evaluate if administration of piperacillin–tazobactam as antibiotic prophylaxis results in decreased 30-day SSI rate compared with cefoxitin in patients undergoing elective PD. Methods and analysis This study will be a multi-institution, double-arm, non-blinded randomised controlled superiority trial. Adults ≥18 years consented to undergo PD for all indications who present to institutions participating in the National Surgical Quality Improvement Program Hepato-Pancreato-Biliary (NSQIP HPB) Collaborative will be included. Data collection will use the NSQIP HPB Collaborative Surgical Clinical Reviewers. Patients will be randomised to either 1–2 g intravenous cefoxitin or 3.375–4.5 g intravenous piperacillin–tazobactam within 60 min of surgical incision. The primary outcome will be 30-day postoperative SSI rate following PD. Secondary outcomes will include 30-day postoperative mortality; specific postoperative complication rate; and unplanned reoperation, length of stay, and hospital readmission. A subset of patients will have bacterial isolates and sensitivities of intraoperative bile cultures and SSIs. Postoperative SSIs and secondary outcomes will be analysed using logistic regression models with the primary predictor as the randomised treatment group. Additional adjustment will be made for preoperative biliary stent presence. Additionally, bacterial cultures and isolates will be summarised by presence of bacterial species and antibiotic sensitivities. Ethics and dissemination This study is approved by the Institutional Review Board at Memorial Sloan Kettering Cancer Center. This trial will evaluate the effect of piperacillin–tazobactam compared with cefoxitin as antibiotic prophylaxis on the hazard of postoperative SSIs. The results will be disseminated regardless of the effect of the intervention on study outcomes. The manuscript describing the effect of the intervention will be submitted to a peer-reviewed journal when data collection and analyses are complete. Trial registration number NCT03269994 ." @default.
• W3135179372 created "2021-03-15" @default.
• W3135179372 creator A5009465403 @default.
• W3135179372 creator A5011555598 @default.
• W3135179372 creator A5037610787 @default.
• W3135179372 creator A5052873370 @default.
• W3135179372 creator A5058498599 @default.
• W3135179372 creator A5065335310 @default.
• W3135179372 creator A5083193232 @default.
• W3135179372 creator A5085283718 @default.
• W3135179372 date "2021-03-01" @default.
• W3135179372 modified "2023-10-12" @default.
• W3135179372 title "Cefoxitin versus piperacillin–tazobactam as surgical antibiotic prophylaxis in patients undergoing pancreatoduodenectomy: protocol for a randomised controlled trial" @default.
• W3135179372 cites W2017426523 @default.
• W3135179372 cites W2039474349 @default.
• W3135179372 cites W2044299192 @default.
• W3135179372 cites W2044352238 @default.
• W3135179372 cites W2044453827 @default.
• W3135179372 cites W2045388310 @default.
• W3135179372 cites W2045813056 @default.
• W3135179372 cites W2047300224 @default.
• W3135179372 cites W2071218337 @default.
• W3135179372 cites W2082844996 @default.
• W3135179372 cites W2094055793 @default.
• W3135179372 cites W2109189914 @default.
• W3135179372 cites W2111911163 @default.
• W3135179372 cites W2123383071 @default.
• W3135179372 cites W2141218183 @default.
• W3135179372 cites W2150701449 @default.
• W3135179372 cites W2155800098 @default.
• W3135179372 cites W2235665815 @default.
• W3135179372 cites W2238452502 @default.
• W3135179372 cites W2332999386 @default.
• W3135179372 cites W2798795107 @default.
• W3135179372 cites W3037587562 @default.
• W3135179372 cites W3094200822 @default.
• W3135179372 cites W2478926885 @default.
• W3135179372 doi "https://doi.org/10.1136/bmjopen-2020-048398" @default.
• W3135179372 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7934720" @default.
• W3135179372 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33664081" @default.
• W3135179372 hasPublicationYear "2021" @default.
• W3135179372 type Work @default.
• W3135179372 sameAs 3135179372 @default.
• W3135179372 citedByCount "6" @default.
• W3135179372 countsByYear W31351793722022 @default.
• W3135179372 countsByYear W31351793722023 @default.
• W3135179372 crossrefType "journal-article" @default.
• W3135179372 hasAuthorship W3135179372A5009465403 @default.
• W3135179372 hasAuthorship W3135179372A5011555598 @default.
• W3135179372 hasAuthorship W3135179372A5037610787 @default.
• W3135179372 hasAuthorship W3135179372A5052873370 @default.
• W3135179372 hasAuthorship W3135179372A5058498599 @default.
• W3135179372 hasAuthorship W3135179372A5065335310 @default.
• W3135179372 hasAuthorship W3135179372A5083193232 @default.
• W3135179372 hasAuthorship W3135179372A5085283718 @default.
• W3135179372 hasBestOaLocation W31351793721 @default.
• W3135179372 hasConcept C141071460 @default.
• W3135179372 hasConcept C168563851 @default.
• W3135179372 hasConcept C2776124114 @default.
• W3135179372 hasConcept C2777637488 @default.
• W3135179372 hasConcept C2777858937 @default.
• W3135179372 hasConcept C2778193466 @default.
• W3135179372 hasConcept C2778266534 @default.
• W3135179372 hasConcept C2778602436 @default.
• W3135179372 hasConcept C2779489039 @default.
• W3135179372 hasConcept C2779631663 @default.
• W3135179372 hasConcept C501593827 @default.
• W3135179372 hasConcept C523546767 @default.
• W3135179372 hasConcept C54355233 @default.
• W3135179372 hasConcept C71924100 @default.
• W3135179372 hasConcept C86803240 @default.
• W3135179372 hasConcept C89423630 @default.
• W3135179372 hasConcept C94665300 @default.
• W3135179372 hasConceptScore W3135179372C141071460 @default.
• W3135179372 hasConceptScore W3135179372C168563851 @default.
• W3135179372 hasConceptScore W3135179372C2776124114 @default.
• W3135179372 hasConceptScore W3135179372C2777637488 @default.
• W3135179372 hasConceptScore W3135179372C2777858937 @default.
• W3135179372 hasConceptScore W3135179372C2778193466 @default.
• W3135179372 hasConceptScore W3135179372C2778266534 @default.
• W3135179372 hasConceptScore W3135179372C2778602436 @default.
• W3135179372 hasConceptScore W3135179372C2779489039 @default.
• W3135179372 hasConceptScore W3135179372C2779631663 @default.
• W3135179372 hasConceptScore W3135179372C501593827 @default.
• W3135179372 hasConceptScore W3135179372C523546767 @default.
• W3135179372 hasConceptScore W3135179372C54355233 @default.
• W3135179372 hasConceptScore W3135179372C71924100 @default.
• W3135179372 hasConceptScore W3135179372C86803240 @default.
• W3135179372 hasConceptScore W3135179372C89423630 @default.
• W3135179372 hasConceptScore W3135179372C94665300 @default.
• W3135179372 hasIssue "3" @default.
• W3135179372 hasLocation W31351793721 @default.
• W3135179372 hasLocation W31351793722 @default.
• W3135179372 hasLocation W31351793723 @default.
• W3135179372 hasOpenAccess W3135179372 @default.
• W3135179372 hasPrimaryLocation W31351793721 @default.
• W3135179372 hasRelatedWork W2054393489 @default.
• W3135179372 hasRelatedWork W2378900461 @default.

• next